By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Relmada Therapeutics 



  New York    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS








Company News
Relmada Therapeutics To Present At The 2015 LD Micro Invitational Conference 5/27/2015 9:58:51 AM
Relmada Therapeutics To Present At The 2015 Marcum MicroCap Conference 5/19/2015 11:18:09 AM
Relmada Therapeutics Announces Notice Of Allowance For U.S. Patent Covering SECUREL(TM), Its Abuse-Deterrent, Extended-Release, Technology Platform For Opioids 5/12/2015 6:50:22 AM
Relmada Therapeutics Commences Proof-of-Concept Clinical Study For Novel Oral Formulations Of Buprenorphine 4/22/2015 3:12:59 PM
Relmada Therapeutics Receives Health Canada Clearance to Further Explore Promising NMDA Receptor Antagonist d-Methadone (REL-1017) 4/16/2015 6:48:09 AM
Relmada Therapeutics Appoints Lisa Nolan, Ph.D. As Senior Vice President Of Business Development 4/8/2015 6:16:47 AM
Relmada Therapeutics Receives Health Canada Clearance To Commence First Clinical Study For Novel Oral Formulations Of Buprenorphine 3/24/2015 6:56:06 AM
Relmada Therapeutics Reports Positive Phase 1 Results For NMDA Receptor Antagonist D-Methadone 3/17/2015 6:42:46 AM
Relmada Therapeutics To Present At Future Leaders In The Biotech Industry Conference 3/12/2015 11:13:24 AM
Relmada Therapeutics Names Leading Clinicians And Researchers In Pain Therapy Development To Advisory Roles 3/5/2015 9:19:32 AM
1234
//-->